Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects.

Kang SM, Tang Q, Bluestone JA.

Am J Transplant. 2007 Jun;7(6):1457-63. Review.

2.

Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.

He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.

Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016. Epub 2009 Apr 19.

PMID:
19486771
3.

Regulatory T cells in transplantation: what we know and what we do not know.

Yeung MY, Sayegh MH.

Transplant Proc. 2009 Jul-Aug;41(6 Suppl):S21-6. doi: 10.1016/j.transproceed.2009.06.093. Epub 2009 Jul 10.

PMID:
19651291
5.

Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.

Schabowsky RH, Madireddi S, Sharma R, Yolcu ES, Shirwan H.

Curr Opin Investig Drugs. 2007 Dec;8(12):1002-8. Review.

PMID:
18058571
6.

Paralysis of CD4(+)CD25(+) regulatory T cell response in chronic autoimmune encephalomyelitis.

Matsumoto Y, Sakuma H, Kohyama K, Park IK.

J Neuroimmunol. 2007 Jul;187(1-2):44-54. Epub 2007 May 17.

PMID:
17499858
7.

Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.

Cao Q, Wang L, Du F, Sheng H, Zhang Y, Wu J, Shen B, Shen T, Zhang J, Li D, Li N.

Cell Res. 2007 Jul;17(7):627-37.

8.

Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants.

Barreto M, Ferreira RC, Lourenço L, Moraes-Fontes MF, Santos E, Alves M, Carvalho C, Martins B, Andreia R, Viana JF, Vasconcelos C, Mota-Vieira L, Ferreira C, Demengeot J, Vicente AM.

BMC Immunol. 2009 Jan 27;10:5. doi: 10.1186/1471-2172-10-5.

9.

Polyclonal expansion of human CD4(+)CD25(+) regulatory T cells.

Hoffmann P, Eder R, Edinger M.

Methods Mol Biol. 2011;677:15-30. doi: 10.1007/978-1-60761-869-0_2.

PMID:
20941600
10.

[Regulatory T cells and their influence in kidney allograft survival].

Velásquez SY, García LF, Alvarez CM.

Medicina (B Aires). 2007;67(5):491-501. Review. Spanish.

PMID:
18051235
11.

Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.

Wang Z, Xiao L, Shi BY, Qian YY, Bai HW, Chang JY, Cai M.

Transpl Immunol. 2008 Apr;19(1):69-73. doi: 10.1016/j.trim.2008.01.005. Epub 2008 Feb 22.

PMID:
18346640
12.

Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.

Yoon IH, Choi SE, Kim YH, Yang SH, Park JH, Park CS, Kim Y, Kim JS, Kim SJ, Simpson E, Park CG.

Transplantation. 2008 Nov 27;86(10):1352-60. doi: 10.1097/TP.0b013e31818aa43c. Erratum in: Transplantation. 2009 Jan 15;87(1):155.

PMID:
19034003
13.

Roles of CD4+CD25(high) FOXP3+ Tregs in lymphomas and tumors are complex.

Ke X, Wang J, Li L, Chen IH, Wang H, Yang XF.

Front Biosci. 2008 May 1;13:3986-4001. Review.

PMID:
18508492
14.

PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.

Franceschini D, Paroli M, Francavilla V, Videtta M, Morrone S, Labbadia G, Cerino A, Mondelli MU, Barnaba V.

J Clin Invest. 2009 Mar;119(3):551-64. doi: 10.1172/JCI36604. Epub 2009 Feb 23.

15.

CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.

Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.

Haematologica. 2008 Mar;93(3):423-30. doi: 10.3324/haematol.11897. Epub 2008 Feb 20.

16.

The role of ACAID and CD4+CD25+FOXP3+ regulatory T cells on CTL function against MHC alloantigens.

Saban DR, Cornelius J, Masli S, Schwartzkopff J, Doyle M, Chauhan SK, Peck AB, Grant MB.

Mol Vis. 2008;14:2435-42. Epub 2008 Dec 19.

17.

Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy.

Zhao JX, Zeng YY, Liu Y.

J Reprod Immunol. 2007 Oct;75(2):71-81. Epub 2007 Aug 7.

PMID:
17686527
18.

Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?

Demirkiran A, Hendrikx TK, Baan CC, van der Laan LJ.

Transplantation. 2008 Mar 27;85(6):783-9. doi: 10.1097/TP.0b013e318166910b.

PMID:
18360256
19.

Regulatory T cells and autoimmunity.

Vila J, Isaacs JD, Anderson AE.

Curr Opin Hematol. 2009 Jul;16(4):274-9. doi: 10.1097/MOH.0b013e32832a9a01. Review.

PMID:
19417650
20.

Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.

Lewkowicz N, Lewkowicz P, Dzitko K, Kur B, Tarkowski M, Kurnatowska A, Tchórzewski H.

J Oral Pathol Med. 2008 Sep;37(8):454-61. doi: 10.1111/j.1600-0714.2008.00661.x. Epub 2008 Mar 3.

PMID:
18318707
Items per page

Supplemental Content

Write to the Help Desk